| ECM: | extracellular matrix |
| PMN: | pre-metastatic niche |
| BMDC: | bone marrow-derived cells |
| MDSC: | myeloid-derived suppressor cells |
| TAM: | tumor-associated macrophage |
| EV: | extracellular vesicles |
| EMT: | epithelial-to-mesenchymal transition |
| CAF: | cancer associated fibroblast |
| HSC: | hematopoietic stem cell |
| BBB: | blood–brain barrier |
| IL-6: | interleukin 6 |
| IL-1β: | interleukin-1β |
| CXCL12/SDF-1 α: | stromal cell-derived factor 1 |
| IL-8: | interleukin 8 |
| VEGF: | vascular endothelial growth factor |
| G-CSF: | granulocyte-colony stimulating factor |
| MIF: | macrophage migration inhibitory factor |
| TIMP-1: | tissue inhibitor of metalloproteinases 1 |
| GM-CSF: | granulocyte–macrophage colony-stimulating factor |
| SAA: | serum amyloid A |
| TGF-β: | transforming growth factor beta |
| HIF-1: | hypoxia-inducible factor 1 |
| CCL2: | CC-chemokine ligand 2 |
| CCL5: | chemokine ligand 5 |
| CXCL1: | C–X–C motif ligand 1 |
| JAK: | Janus kinase |
| STAT3: | signal transducer and activator of transcription 3 |
| AKT: | protein kinase B |
| MAPK: | mitogen-activated protein kinase |
| IDO: | indoleamine 2,3-dioxygenase |
| PD-L1: | programmed death ligand 1 |